SPR1020
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPR1020, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]